Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-7479d7b7d-68ccn Total loading time: 0 Render date: 2024-07-12T11:54:17.896Z Has data issue: false hasContentIssue false

Chapter 16 - Cardio-thoracic tumors

Published online by Cambridge University Press:  05 November 2015

By
Umberto Malapelle ,
Claudio Bellevicine ,
Elena Vigliar  and
Giancarlo Troncone
Edited by
John M. S. Bartlett ,
Abeer Shaaban  and
Fernando Schmitt
John M. S. Bartlett
Affiliation:
Ontario Institute for Cancer Research, Toronto
Abeer Shaaban
Affiliation:
Queen Elizabeth Hospital Birmingham
Fernando Schmitt
Affiliation:
University of Porto
Get access
Type
Chapter
Information
Molecular Pathology
A Practical Guide for the Surgical Pathologist and Cytopathologist
 , pp. 247 - 275
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Mok, T. S., Wu, Y. L., Thongprasert, S., Yang, C. H., Chu, D. T., Saijo, N. et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. New Engl J Med 2009; 361(10): 947–57. PubMed PMID: 19692680.CrossRefGoogle ScholarPubMed
Thunnissen, E., Bubendorf, L., Dietel, M., Elmberger, G., Kerr, K., Lopez-Rios, F. et al. EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations. Virchows Arch 2012; 461(3): 245–57. PubMed PMID: 22825000. Pubmed Central PMCID: PMC3432214. Epub: 2012/07/25.eng.CrossRefGoogle Scholar
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y. et al. International association for the study of lung cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6(2): 244–85. PubMed PMID: 21252716.CrossRefGoogle Scholar
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G. et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med 2013; 137(6): 828–60. PubMed PMID: 23551194. Epub: 2013/04/05.eng.CrossRefGoogle Scholar
Aisner, D. L. and Marshall, C. B. Molecular pathology of non-small cell lung cancer: a practical guide. Am J Clin Pathol 2012; 138(3): 332–46. PubMed PMID: 22912349. Epub: 2012/08/23.eng.CrossRefGoogle ScholarPubMed
Thunnissen, E., Kerr, K. M., Herth, F. J., Lantuejoul, S., Papotti, M., Rintoul, R. C. et al. The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group. Lung Cancer 2012; 76(1):1–18. PubMed PMID: 22138001. Epub: 2011/12/06.eng.CrossRefGoogle ScholarPubMed
Malapelle, U., Bellevicine, C., Zeppa, P., Palombini, L. and Troncone, G. Cytology-based gene mutation tests to predict response to anti-epidermal growth factor receptor therapy: a review. Diagn Cytopathol 2011; 39(9): 703–10. PubMed PMID: 21837660.CrossRefGoogle ScholarPubMed
Yatabe, Y., Matsuo, K. and Mitsudomi, T. Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma. J Clin Oncol 2011; 29(22): 2972–7. PubMed PMID: 21730270.CrossRefGoogle ScholarPubMed
Malapelle, U., Bellevicine, C., de Luca, C., Salatiello, M., de Stefano, A., Rocco, D. et al. EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to Gefitinib in non small cell lung cancer patients. Cancer Cytopathol 2013; 121(10): 552–60.CrossRefGoogle Scholar
Malapelle, U., Russo, S., Pepe, F., Sgariglia, R., De Luca, C., Bellevicine, C. et al. EGFR mutation detection by microfluidic technology: a validation study. J Clin Pathol 2013; 66(11): 982–4. PubMed PMID: 23794480. Epub: 2013/06/25.eng.CrossRefGoogle ScholarPubMed
Shames, D. S. and Wistuba, I. I. The evolving genomic classification of lung cancer. J Pathol 2013; 232(2): 121–33. PubMed PMID: 24114583. Epub: 2013/10/12.eng.Google Scholar
Han, H. S., Lim, S. N., An, J. Y., Lee, K. M., Choe, K. H., Lee, K. H. et al. Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differential sensitivity. J Thorac Oncol 2012; 7(2): 355–64. PubMed PMID: 22157369.CrossRefGoogle ScholarPubMed
Chin, E. L., da Silva, C. and Hegde, M. Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations. BMC Genet 2013; 14: 6. PubMed PMID: 23418865. Epub: 2013/02/20.eng.CrossRefGoogle ScholarPubMed
Buttitta, F., Felicioni, L., Del Grammastro, M., Filice, G., Di Lorito, A., Malatesta, S. et al. Effective assessment of EGFR mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing. Clin Cancer Res 2013; 19(3): 691–8. PubMed PMID: 23243218.CrossRefGoogle ScholarPubMed
Pirker, R., Herth, F. J., Kerr, K. M., Filipits, M., Taron, M., Gandara, D. et al. Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol 2010; 5(10): 1706–13. PubMed PMID: 20871269.CrossRefGoogle ScholarPubMed
Lozano, M. D., Zulueta, J. J., Echeveste, J. I., Gurpide, A., Seijo, L. M., Martin-Algarra, S. et al. Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes. Oncologist 2011; 16(6): 877–85. PubMed PMID: 21572125.CrossRefGoogle ScholarPubMed
Bozzetti, C., Negri, F. V., Azzoni, C., Naldi, N., Nizzoli, R., Bortesi, B. et al. Epidermal growth factor receptor and Kras gene expression: reliability of mutational analysis on cytological samples. Diagn Cytopathol 2013; 41(7): 595–8. PubMed PMID: 22833420. Epub: 2012/07/27.eng.CrossRefGoogle ScholarPubMed
Bruno, P., Mariotta, S., Ricci, A., Duranti, E., Scozzi, D., Noto, A. et al. Reliability of direct sequencing of EGFR: comparison between cytological and histological samples from the same patient. Anticancer Res 2011; 31(12): 4207–10. PubMed PMID: 22199282. Epub: 2011/12/27.eng.Google ScholarPubMed
Chowdhuri, S. R., Xi, L., Pham, T. H., Hanson, J., Rodriguez-Canales, J., Berman, A. et al. EGFR and KRAS mutation analysis in cytologic samples of lung adenocarcinoma enabled by laser capture microdissection. Mod Pathol 2012; 25(4): 548–55. PubMed PMID: 22157931.CrossRefGoogle ScholarPubMed
Goto, K., Satouchi, M., Ishii, G., Nishio, K., Hagiwara, K., Mitsudomi, T. et al. An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting. Ann Oncol 2012; 23(11): 2914–19. PubMed PMID: 22776705. Epub: 2012/07/11.eng.CrossRefGoogle ScholarPubMed
Mitiushkina, N. V., Iyevleva, A. G., Poltoratskiy, A. N., Ivantsov, A. O., Togo, A. V., Polyakov, I. S. et al. Detection of EGFR mutations and EML4-ALK rearrangements in lung adenocarcinomas using archived cytological slides. Cancer Cytopathol 2013; 121(7): 370–6. PubMed PMID: 23408463. Epub: 2013/02/15.eng.CrossRefGoogle ScholarPubMed
Sun, P. L., Jin, Y., Kim, H., Lee, C. T., Jheon, S. and Chung, J. H. High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas. Cancer Cytopathol 2013; 121(6): 311–19.CrossRefGoogle ScholarPubMed
Khode, R., Larsen, D. A., Culbreath, B. C., Parrish, S., Walker, K. L., Sayage-Rabie, L. et al. Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas. Cancer Cytopathol 2013; 121(7): 361–9. PubMed PMID: 23364874. Epub 2013/02/01.eng.CrossRefGoogle ScholarPubMed
Malapelle, U., de Rosa, N., Rocco, D., Bellevicine, C., Crispino, C., Illiano, A. et al. EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study. J Clin Pathol 2012; 65(1): 87–91. PubMed PMID: 21945923.CrossRefGoogle ScholarPubMed
Thunnissen, E., Bovee, J. V., Bruinsma, H., van den Brule, A. J., Dinjens, W., Heideman, D. A. et al. EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy. J Clin Pathol 2011; 64(10): 884–92. PubMed PMID: 21947301. Epub: 2011/09/29.eng.CrossRefGoogle ScholarPubMed
Mazieres, J., Peters, S., Lepage, B., Cortot, A. B., Barlesi, F., Beau-Faller, M. et al. Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives. J Clin Oncol 2013; 31(16): 1997–2003. PubMed PMID: 23610105. Epub: 2013/04/24.eng.CrossRefGoogle ScholarPubMed
Davies, K. D., Le, A. T., Theodoro, M. F., Skokan, M. C., Aisner, D. L., Berge, E. M. et al. Identifying and targeting ROS1 gene fusions in non-small cell lung cancer. Clin Cancer Res 2012; 18(17): 4570–9. PubMed PMID: 22919003. Pubmed Central PMCID: PMC3703205. Epub: 2012/08/25.eng.CrossRefGoogle ScholarPubMed
Borrelli, N., Giannini, R., Proietti, A., Ali, G., Pelliccioni, S., Niccoli, C. et al. KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung. Lung Cancer 2013; 81(3): 377–81. PubMed PMID: 23891510. Epub: 2013/07/31.eng.CrossRefGoogle Scholar
Cardarella, S., Ogino, A., Nishino, M., Butaney, M., Shen, J., Lydon, C. et al. Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer. Clin Cancer Res 2013; 19(16): 4532–40. PubMed PMID: 23833300. Pubmed Central PMCID: PMC3762878. Epub: 2013/07/09.eng.CrossRefGoogle ScholarPubMed
Chiosea, S. I., Sherer, C. K., Jelic, T. and Dacic, S. KRAS mutant allele-specific imbalance in lung adenocarcinoma. Mod Pathol; 24(12): 1571–7. PubMed PMID: 21743433.Google Scholar
Ohashi, K., Sequist, L. V., Arcila, M. E., Lovly, C. M., Chen, X., Rudin, C. M. et al. Characteristics of lung cancers harboring NRAS mutations. Clin Cancer Res 2013; 19(9): 2584–91. PubMed PMID: 23515407. Pubmed Central PMCID: PMC3643999. Epub: 2013/03/22.eng.CrossRefGoogle ScholarPubMed
Tada, Y., Shimada, H., Hiroshima, K. and Tagawa, M. A potential therapeutic strategy for malignant mesothelioma with gene medicine. BioMed Res Int 2013; 2013: article ID 572609. PubMed PMID: 23484132. Pubmed Central PMCID: PMC3581274. Epub: 2013/03/14.eng.CrossRefGoogle ScholarPubMed
Sekido, Y. Molecular pathogenesis of malignant mesothelioma. Carcinogenesis 2013; 34(7): 1413–19. PubMed PMID: 23677068. Epub: 2013/05/17.eng.CrossRefGoogle ScholarPubMed
Jean, D., Daubriac, J., Le Pimpec-Barthes, F., Galateau-Salle, F. and Jaurand, M. C. Molecular changes in mesothelioma with an impact on prognosis and treatment. Arch Pathol Lab Med 2012; 136(3): 277–93. PubMed PMID: 22372904. Epub: 2012/03/01.eng.CrossRefGoogle ScholarPubMed
Elbardissi, A. W., Dearani, J. A., Daly, R. C., Mullany, C. J., Orszulak, T. A., Puga, F. J. et al. Survival after resection of primary cardiac tumors: a 48-year experience. Circulation 2008; 118(14 Suppl.): S7–15. PubMed PMID: 18824772.CrossRefGoogle ScholarPubMed
Singhal, P., Luk, A., Rao, V. and Butany, J. Molecular basis of cardiac myxomas. Int J Mol Sci 2014; 15(1): 1315–37. PubMed PMID: 24447924.en.CrossRefGoogle ScholarPubMed
Lee, K. A., Won, H.-S., Shim, J.-Y., Lee, P. R. and Kim, A. Molecular genetic, cardiac and neurodevelopmental findings in cases of prenatally diagnosed rhabdomyoma associated with tuberous sclerosis complex. Ultrasound in Obstet Gynecol 2013; 41: 306–11. PubMed PMID: 22791573.CrossRefGoogle ScholarPubMed
Scanlan, D., Radio, S. J., Nelson, M., Zhou, M., Streblow, R., Prasad, V. et al. Loss of the PTCH1 gene locus in cardiac fibroma. Cardiovasc Pathol 2008; 17(2): 93–7. PubMed PMID: 18329553. Pubmed Central PMCID: 2342874.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×